Aarhus University Seal / Aarhus Universitets segl

Impact of Growth Factor Independence 1 in Human T-Cell Lymphomas: Pathogenic Potential Identified by Insertional Mutagenesis in a Murine T-Cell Lymphoma Model

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperConference abstract in journalResearch

  • Magdalena Julia Dabrowska, Denmark
  • Karen Dybkær, Denmark
  • Preben Johansen, Patologisk Institut, Aalborg Sygehus, Århus Universitetshospital, Denmark
  • Hans Erik Johnsen, Denmark
  • Finn Skou Pedersen
  • Hæmatologisk Afdeling, Aalborg Sygehus
  • Department of Molecular Biology
  • Patologisk Institut, Aalborg Sygehus Nord

Impact of Growth Factor Independence 1 in Human T-Cell Lymphomas; Pathogenic Potential Identified by Insertional Mutagenesis in a Murine T-Cell Lymphoma Model.

Magdalena Julia Dabrowska*,1, Karen Dybkaer*,1, Preben Johansen*,2, Hans Erik Johnsen1 and Finn Skou Pedersen*,3

1 Department of Hematology, Aalborg Hospital, Aalborg, Denmark,
2 Department of Pathology, Aalborg Hospital, Aalborg, Denmark,
3 Department of Molecular Biology, Aarhus University, Aarhus, Denmark

 

Abstract 5047

Introduction: The transcriptional repressor and oncogene Growth factor independence 1 (Gfi1) has a major oncogenic potential and is aberrantly expressed in murine lymphomas and several human cancers. Gfi1 is a key regulator of stem cell quiescence and plays a significant role in T-cell development, lineage commitment, and influences development of maturate granulocytes and monocytes. The genomic locus on murine chromosome 5 encoding Gfi1 is a frequent integration locus activated in T-cell lymphomas induced by the SL3-3 Murine Leukemia Virus (MLV) as well as other MLVs, indicating that Gfi1 is essential in development of these tumors. In the SL3-3 induced T-cell lymphoma model, retroviral insertions in the Gfi1 3'UTR have been demonstrated to decouple microRNA-mediated posttranscriptional regulation of protein expression (Dabrowska et al, 2009) further supporting its role in lymphomagenesis. In human cancers, Gfi1 protein expression has been observed in HTLV-1 induced ATLL and SCLC but no knowledge exists on how Gfi1 contributes to initiating and maintaining human T-cell lymphomas.

Methods: Gfi1 gene and protein expression patterns were determined in precursor and mature human T-cell lymphomas by real time PCR and Western blot analysis. Furthermore, localization and expression patterns of the Gfi1 protein was determined in the human T-cell lymphomas by immunohistochemical staining with Gfi1 antibodies and compared to similar staining of MLV induced tumors.

Results: Our results demonstrated that Gfi1 mRNA and protein levels vary significantly among the human T-cell lymphomas, and do not always show a direct proportional pattern. Thus, Gfi1 mRNA expression can be relatively high without resulting in a corresponding high protein expression, suggesting that a microRNA mediated posttranscriptional regulation exists in some tumors but may be disrupted in others. Furthermore, an additional Gfi1 protein variant was identified in one of the T-cell lymphoma entities. Immunohistochemical staining demonstrated varying Gfi1 protein expression in both nucleus and cytoplasm in the T-cell lymphomas and different distributions of the protein within the tumor and tumor cells were observed among samples. Staining of normal human tonsil demonstrated Gfi1 protein to be localized in the cytoplasm. We hypothesise that regulation of Gfi1 may include shuttling between cytoplasm and nucleus and that lymphomagenesis enables unlimited nuclear access.

Conclusion: Our data shows that deregulated Gfi1 expression plays a major role in the development of MLV induced lymphomas and strongly indicates that retroviral insertional mutagenesis in murine models of human NHLs can be used to identify new genes involved in lymphomagenesis and, by use of functional assays, their impact on human lymphomas can be evaluated.

Disclosures: No relevant conflicts of interest to declare.

Original languageEnglish
JournalBlood
Issue22
Pages (from-to)Abstract 5047
ISSN0006-4971
Publication statusPublished - 2009
Event51st ASH Annual Meeting and Exposition - New Orleans, United States
Duration: 3 Dec 20098 Dec 2009
Conference number: 51

Conference

Conference51st ASH Annual Meeting and Exposition
Number51
CountryUnited States
CityNew Orleans
Period03/12/200908/12/2009

See relations at Aarhus University Citationformats

ID: 19208752